BBC -- The makers of Gaviscon maintained an effective monopoly on the market for years after the stomach medicine came off patent, Newsnight has been told. Internal documents show Reckitt Benckiser executives schemed to create obstacles to block rival manufacturers from selling cheap generic copies. Read full article below.
